tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

CALT Stock Latest News

Calliditas Therapeutics’ nefecon featured in four posters at nephrology congress
The FlyCalliditas Therapeutics’ nefecon featured in four posters at nephrology congress
7d ago
CALT
Calliditas gets additional seven year orphan drug exclusivity period for Tarpeyo
PremiumThe Fly
Calliditas gets additional seven year orphan drug exclusivity period for Tarpeyo
2M ago
CALT
Calliditas Therapeutics provides business update ahead of conference
PremiumThe Fly
Calliditas Therapeutics provides business update ahead of conference
4M ago
CALT
Calliditas Therapeutics appoints Maria Tornsen as President North America
PremiumThe Fly
Calliditas Therapeutics appoints Maria Tornsen as President North America
4M ago
CALT
Calliditas Therapeutics’ Tarpeyo granted full FDA aproval for IgA nephropathy
PremiumThe Fly
Calliditas Therapeutics’ Tarpeyo granted full FDA aproval for IgA nephropathy
4M ago
CALT
Calliditas announces Notice of Allowance for U.S. Patent Application for Tarpeyo
PremiumThe FlyCalliditas announces Notice of Allowance for U.S. Patent Application for Tarpeyo
5M ago
CALT
Calliditas Therapeutics initiates setanaxib study
PremiumThe Fly
Calliditas Therapeutics initiates setanaxib study
5M ago
CALT
Calliditas announces Everest Medicines receives approval for Nefecon
PremiumThe Fly
Calliditas announces Everest Medicines receives approval for Nefecon
6M ago
CALT
Omeros’ failure alleviates competition for Calliditas, says H.C. Wainwright
PremiumThe Fly
Omeros’ failure alleviates competition for Calliditas, says H.C. Wainwright
6M ago
CALT
OMER
Calliditas Therapeutics announces COMP opinion on setanaxib
PremiumThe Fly
Calliditas Therapeutics announces COMP opinion on setanaxib
7M ago
CALT
Calliditas Therapeutics presents Phase 3 NefIgArd study data
PremiumThe Fly
Calliditas Therapeutics presents Phase 3 NefIgArd study data
7M ago
CALT
Calliditas Therapeutics partner submits request to MHRA to convert Kinpeygo CMA
PremiumThe Fly
Calliditas Therapeutics partner submits request to MHRA to convert Kinpeygo CMA
7M ago
CALT
Calliditas Therapeutics presents data from the NefIgArd Phase 3 trial
PremiumThe FlyCalliditas Therapeutics presents data from the NefIgArd Phase 3 trial
7M ago
CALT
Stada, Calliditas submit EMA request to convert Kinpeygo marketing authorization
PremiumThe Fly
Stada, Calliditas submit EMA request to convert Kinpeygo marketing authorization
7M ago
CALT
Calliditas Therapeutics confirms FDA orphan drug designation granted
PremiumThe Fly
Calliditas Therapeutics confirms FDA orphan drug designation granted
7M ago
CALT
Calliditas gets FDA orphan designation for treatment of Alport syndrome
PremiumThe Fly
Calliditas gets FDA orphan designation for treatment of Alport syndrome
7M ago
CALT
H.C. Wainwright keeps $50 target on Calliditas after Travere data
PremiumThe Fly
H.C. Wainwright keeps $50 target on Calliditas after Travere data
7M ago
CALT
Calliditas Therapeutics price target lowered to $50 from $60 at H.C. Wainwright
PremiumThe Fly
Calliditas Therapeutics price target lowered to $50 from $60 at H.C. Wainwright
8M ago
CALT
Calliditas Therapeutics price target lowered to $18 from $21 at Guggenheim
PremiumThe Fly
Calliditas Therapeutics price target lowered to $18 from $21 at Guggenheim
8M ago
CALT
Calliditas Therapeutics announces FDA acceptance of Tarpeyo sNDA
PremiumThe FlyCalliditas Therapeutics announces FDA acceptance of Tarpeyo sNDA
8M ago
CALT
Calliditas Therapeutics’ NefIgArd phase 3 trial results published in The Lancet
PremiumThe Fly
Calliditas Therapeutics’ NefIgArd phase 3 trial results published in The Lancet
8M ago
CALT
Calliditas Therapeutics reports publication of NefIgArd Study data in The Lancet
PremiumThe Fly
Calliditas Therapeutics reports publication of NefIgArd Study data in The Lancet
8M ago
CALT

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >